Curaleaf Holdings (CURLF) Enterprise Value (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Enterprise Value of -$101.6 million for Q4 2025, up 5.27% year-on-year from -$96.5 million in Q4 2024, and up 5.27% on a QoQ basis from -$107.2 million in Q4 2024.

Curaleaf Holdings (CURLF) Enterprise Value (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Enterprise Value for 7 consecutive years, with -$101.6 million the latest figure, recorded in Q4 2025.

  • Quarterly Enterprise Value rose 5.27% year-over-year to -$101.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$101.6 million (up 5.27% YoY) and the FY2025 annual result came in at -$101.6 million, up 5.27% from the prior year.
  • Enterprise Value advanced to -$101.6 million in Q4 2025 per CURLF's latest filing, from -$107.2 million in the prior quarter.
  • Over the last five years, Enterprise Value for CURLF reached as high as $116.5 billion in Q1 2022 and fell as low as -$312.5 million in Q1 2021.
  • A 5-year average of $7.7 billion and a median of $24.9 million in 2024 frame the typical range for Enterprise Value.
  • Annual changes were most pronounced in 2022 — Enterprise Value jumped 37395.09% — and 2024, when it slumped 471.9%.
  • Year by year, Enterprise Value stood at $45.4 million in 2021, then tumbled by 192.59% to -$42.1 million in 2022, then surged by 168.54% to $28.8 million in 2023, then sank by 471.9% to -$107.2 million in 2024, then gained by 5.27% to -$101.6 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$101.6 million, -$107.2 million, and $35.8 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -1.86 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -3.74 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -1.94 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -4.05 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -2.15 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -33.59 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -1.80 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -1.32 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -428.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -101.57 Mn
Dec 31, 2024 -107.23 Mn
Sep 30, 2024 35.77 Mn
Jun 30, 2024 24.94 Mn
Dec 31, 2023 28.83 Mn
Sep 30, 2023 1.17 Mn
Jun 30, 2023 38.28 Mn
Dec 31, 2022 -42.06 Mn
Sep 30, 2022 118.02 Mn
Jun 30, 2022 112.14 Mn
Mar 31, 2022 116.55 Bn
Dec 31, 2021 45.43 Mn
Sep 30, 2021 -191.28 Mn
Jun 30, 2021 -203.42 Mn
Mar 31, 2021 -312.50 Mn
Dec 31, 2020 -71.45 Mn
Sep 30, 2020 -82.66 Mn
Dec 31, 2019 -44.93 Mn